REGN

Regeneron Pharmaceuticals, Inc. is a leading American biotechnology company based in Westchester County, New York, recognized for its innovative research in monoclonal antibodies and therapeutic proteins. The company has established a strong presence in key therapeutic areas, including oncology, ophthalmology, and immunology, with flagship products such as Eylea and Dupixent driving its success. Regeneron maintains a robust product pipeline, underscoring its dedication to scientific advancement and its influential role in addressing critical unmet medical needs within the biopharmaceutical industry.